Recommended Prednisolone Dosage for Acute Bell's Palsy
For adults ≥16 years presenting within 72 hours of symptom onset, prescribe prednisolone 50 mg once daily for 10 consecutive days without tapering, or alternatively prednisone 60 mg once daily for 5 days followed by a 5-day taper (reducing by 10 mg each day: 50→40→30→20→10 mg, then stop). 1
Evidence Supporting This Recommendation
The American Academy of Otolaryngology-Head and Neck Surgery provides a strong recommendation for oral corticosteroids based on high-quality randomized controlled trials demonstrating significant benefit 2, 1:
- 83% complete recovery at 3 months with prednisolone versus 63.6% with placebo (absolute benefit +19.4%; number needed to treat = 6) 1, 3
- 94.4% complete recovery at 9 months with prednisolone versus 81.6% with placebo (absolute benefit +12.8%; number needed to treat = 8) 1, 3
The BELLS trial—the largest and highest-quality study (n=496)—specifically validated the 50 mg daily prednisolone regimen and found no additional benefit from adding antiviral therapy 3.
Critical Timing Window
Treatment must begin within 72 hours of symptom onset; initiating steroids after this window provides no proven benefit and is not recommended 1, 4. The 72-hour cutoff reflects the pathophysiology: early corticosteroids reduce facial nerve inflammation before permanent damage occurs 4. All efficacy trials enrolled patients within this window 4.
Dosing Details and Common Pitfalls
Correct Dosing Regimens
Option 1 (preferred): Prednisolone 50 mg orally once daily for 10 days, then stop 1
Option 2: Prednisone 60 mg orally once daily for 5 days, then taper by 10 mg daily (50→40→30→20→10 mg) over the next 5 days, stopping on day 11 1
Both regimens deliver approximately 540 mg total prednisone-equivalent exposure over 10–11 days 1.
Critical Pitfall: Standard Methylprednisolone Dose Packs Are Inadequate
A standard methylprednisolone dose pack delivers only ~105 mg prednisone-equivalent over 6 days—far below the required 540 mg—and represents significant underdosing that compromises treatment efficacy 1. Always prescribe the full 10-day prednisolone or tapered prednisone regimen instead 1.
Pediatric Dosing (Age <16 Years)
Evidence for steroid benefit in children is inconclusive 2, 1. A 2022 randomized trial (n=187) found no significant difference between prednisolone and placebo at 1 month (49% vs 57% complete recovery, p=NS), though the study was underpowered 5. Children have higher spontaneous recovery rates (up to 94%) than adults 1.
If treating a child, use weight-based dosing: prednisolone 1 mg/kg/day (maximum 50–60 mg) for 5 days followed by a 5-day taper, with substantial caregiver involvement in shared decision-making 1. However, most children recover completely without treatment 1, 5.
Special Populations
Diabetes Mellitus
Diabetes is not a contraindication to corticosteroid therapy; the therapeutic benefit outweighs the risk of temporary hyperglycemia 1. Monitor capillary blood glucose every 2–4 hours during the first few days, dose steroids in the morning to align with natural cortisol rhythm, and proactively increase basal and prandial insulin 1.
Pregnancy
Pregnant women should receive oral corticosteroids within 72 hours after individualized risk-benefit assessment 2, 1. The guideline acknowledges pregnancy as an exception requiring careful consideration but does not contraindicate treatment 2.
Morbid Obesity and Previous Steroid Intolerance
These conditions are listed as exceptions requiring individualized assessment 2, but the guideline does not provide specific alternative regimens. In practice, the standard dose remains appropriate unless specific contraindications exist.
Antiviral Therapy: Optional Adjunct Only
Antiviral monotherapy (acyclovir or valacyclovir alone) is never appropriate and should not be prescribed 2, 1, 3. The BELLS trial definitively showed no benefit: 71.2% recovery with acyclovir versus 75.7% without (p=0.50) 3.
Combination therapy (antiviral + steroid) may be offered as an option within 72 hours for severe cases, but the added benefit is small 2, 1:
- One trial (n=221) reported 96.5% recovery with valacyclovir + prednisolone versus 89.7% with prednisolone alone (absolute benefit +6.8%) 2
- However, the BELLS trial found no significant advantage of adding acyclovir to prednisolone 3
If combination therapy is chosen, use valacyclovir 1000 mg three times daily for 7 days or acyclovir 400 mg five times daily for 10 days, always in addition to—never instead of—corticosteroids 1.
Mandatory Eye Protection
All patients with impaired eye closure require immediate eye protection to prevent corneal damage 2, 1:
- Lubricating ophthalmic drops every 1–2 hours while awake 1
- Ophthalmic ointment at bedtime 1
- Eye taping or patching at night (with careful instruction to avoid corneal abrasion) 1
- Sunglasses outdoors 1
This is a strong recommendation based on expert opinion and clinical rationale 2.
Follow-Up and Referral Triggers
Refer to a facial nerve specialist if 1:
- Incomplete facial recovery at 3 months after symptom onset
- New or worsening neurologic findings at any point
- Development of ocular symptoms at any point
Approximately 70% of patients with complete paralysis recover fully within 6 months, and patients with incomplete paralysis have recovery rates up to 94% 1, 4.
What NOT to Do
- Do not order routine laboratory tests or imaging for typical Bell's palsy presentations; this delays treatment beyond the critical 72-hour window 1
- Do not prescribe antiviral monotherapy; it is ineffective 2, 1, 3
- Do not initiate steroids after 72 hours; there is no evidence of benefit 1, 4
- Do not use a standard methylprednisolone dose pack; it provides inadequate dosing 1